Apellis Pharmaceuticals, Inc. · NASDAQ:APLS

Deep Track Capital, LP reported a 5.57% stake in Apellis Pharmaceuticals, Inc. (Schedule 13G)

Event May 9, 2025 · Filed May 16, 2025

Deep Track Capital, LP reported a 5.57% stake in Apellis Pharmaceuticals, Inc., 7,000,000 shares, as a passive investor on May 9, 2025. Filed May 16, 2025 (Schedule 13G).

Stake
5.57%
Shares
7,000,000
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Deep Track Capital, LP5.57%7,000,000
Deep Track Biotechnology Master Fund, Ltd.5.57%7,000,000
David Kroin5.57%7,000,000

Source

View original at SEC

Related